XOMA Royalty to Acquire Generation Bio
The acquisition provides XOMA Royalty with potential milestone and royalty payments under Generation Bio’s collaboration with Moderna.
Merger Agreement | 17/12/2025 | By News Bureau
Titan Pharmaceuticals Enters into Merger Agreement with KE
Titan Pharmaceuticals, Inc. has signed a merger, contribution, and contribution and share exchange agreement, regarding a business combination with KE Sdn. Bhd. (KE).
Merger Agreement | 20/08/2024 | By Aishwarya | 312
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy